How Has The Advanced Drug Delivery Systems Market Size Evolved In Recent Years?
The advanced drug delivery systems market has seen considerable growth due to a variety of factors.
•The market size of advanced drug delivery systems has seen robust growth in recent years. It is projected to increase from $269.99 billion in 2024 to $287.82 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%.
Factors contributing to the growth during the historical period include enhanced patient compliance, expiration of drug patents, emergence of personalized medicine, prevalence of chronic diseases, and the usage of biologics and large molecule drugs.
What Is The Projected Growth Of The Advanced Drug Delivery Systems Market?
The advanced drug delivery systems market is expected to maintain its strong growth trajectory in upcoming years.
• In the next few years, the advanced drug delivery systems market is set to experience a significant increase in size, with projections indicating it will reach $404.26 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.9%.
This growth during the forecast period could be largely credited to elements such as user-friendly routes of administration, specialized attention on rare diseases, digital health integration, patient-centered drug development efforts, telehealth impact, gene and rna therapies, exosome-based drug delivery methods, and remote monitoring equipment. Furthermore, key trends expected during the forecast period include developments in nanotechnology, intelligent drug delivery systems, the use of 3D printing in drug formulations, the inclusion of artificial intelligence, and sustainable drug delivery methods.
What Key Factors and Trends are Driving the Growth of the Advanced Drug Delivery Systems Market?
The rise in chronic conditions is seen as a key factor fuelling the expansion of the advanced drug delivery systems market. These conditions, which last for a year or more, require ongoing medical attention while limiting ordinary activities. They are often caused by various risky behaviors such as tobacco use, exposure to secondhand smoke, poor diet, physical inactivity, and excessive drinking. Advanced drug delivery systems offer the advantage of delivering therapeutic agents to specific parts of the body impacted by chronic conditions. They ensure that the drug is delivered to the right place, enhancing its efficacy while reducing side effects. For example, The United Nations (UN), an intergovernmental organization based in the US which strives to encourage international cooperation and preserve international peace and security, stated in May 2023 that chronic diseases are the cause of seven out of 10 deaths in the US, resulting in more than 1.7 million American deaths each year. As such, the escalating prevalence of chronic ailments is serving at the catalyst for the growth of the advanced drug delivery systems market.
What are the Market Segments in the Advanced Drug Delivery Systems Market?
The advanced drug delivery systems market covered in this report is segmented –
1) By Type: Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types
2) By Carrier Type: Liposomes, Nanoparticles, Microspheres, Monoclonal Antibodies, Other Carrier Types
3) By Technology: Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies
4) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS (Central Nervous System), Ophthalmology, Inflammatory Diseases, Infections, Other Applications
5) By End User: Hospitals, Specialized clinics, Clinical Research And Development Centers
Subsegments:
1) By Oral Drug Delivery System: Solid Dosage Forms, Liquid Dosage Forms, Novel Oral Delivery Systems
2) By Injection-Based Drug Delivery System: Conventional Injection Systems (Syringes, Vials), Prefilled Syringes, Autoinjectors, Microneedle-Based Systems
3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers
4) By Transdermal Drug Delivery System: Transdermal Patches, Microneedle Patches, Iontophoresis Systems
5) By Transmucosal Drug Delivery System: Buccal Delivery Systems, Sublingual Delivery Systems, Nasal Delivery Systems, Rectal Delivery Systems
6) By Carrier-Based Drug Delivery System: Liposomes, Nanoparticles, Dendrimers, Niosomes
7) By Other Types: Implantable Drug Delivery Systems, Targeted Delivery Systems, Bioadhesive Drug Delivery Systems
Pre-Book The Advanced Drug Delivery Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Advanced Drug Delivery Systems Market?
Technological advancements are becoming a significant trend in the advanced drug delivery systems market. Companies that are major players in this market are utilizing innovative technologies to maintain their market standing. An excellent example of this is Shilpa Medicare Limited, a manufacturer and supplier of API and formulation from India. In June 2023, they launched Molshil, which is the first-ever oral thin film formulation of a pediatric dose of paracetamol in the world. This new paracetamol formulation offers numerous advantages, such as being highly palatable and easy to administer, and it also eliminates several limitations typical of pediatric formulations.
Who Are the Key Players in the Advanced Drug Delivery Systems Market?
Major companies operating in the advanced drug delivery systems market include:
• Pfizer Inc.
• Johnson and Johnson Services Inc.
• Roche Holding AG
• Abbvie Inc.
• Bayer AG
• Novartis AG
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• 3M Company
• Medtronic plc
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Amgen Inc.
• Merck Group
• Becton Dickinson and Company
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Boston Scientific Corporation
• Mylan N.V.
• Astellas Pharma Inc.
• Catalent Inc.
• Nipro Corporation
• AptarGroup Inc.
• West Pharmaceutical Services Inc.
• Gerresheimer AG
• Insulet Corporation
What are the Regional Insights into the Advanced Drug Delivery Systems Market?
North America was the largest region in the advanced drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
